Cancer52 Annual Review 2023-2024
- cancer52
- Feb 13
- 1 min read
Cancer52 is pleased to submit their Annual Review for the financial year 2023-2024 to the Charity Commission. As ever it is an excellent opportunity to recall the progress made, alongside the Cancer52 membership, on behalf of people affected by rare and less common cancers.
Comentários